About BrainStorm Cell Therapeutics
BrainStorm Cell Therapeutics (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig’s disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD).
State of Ownership
Managing Director, Thoroughly Good Consulting
Sales Account Executive, Springer Nature
CEO & Co-Founder, Zapnito
Former Head of Communities, Springer Nature